UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVL
6201
Direxion Daily AVGO Bull 2X ETF
AVL
$230M
| $291K | ﹤0.01% |
+8,370
| New | +$204K |
|
6202
International General Insurance
IGIC
$1.15B
| $291K | ﹤0.01% |
12,237
-2,973
| -20% | -$67.8K |
|
|
SABA
6203
Saba Capital Income & Opportunities Fund II
SABA
$223M
| $290K | ﹤0.01% |
32,020
-2,481
| -7% | -$21.7K |
|
6204
Oak Valley Bancorp
OVLY
$281M
| $289K | ﹤0.01% |
9,876
+614
| +7% | +$17.6K |
|
6205
First Trust Active Global Quality Income ETF
AGQI
$56M
| $289K | ﹤0.01% |
21,553
+10,745
| +99% | +$151K |
|
6206
CALL
Brookfield
BN
$108B
| $288K | ﹤0.01% |
+7,530
| New | +$284K |
|
|
DHF
6207
BNY Mellon High Yield Strategies Fund
DHF
$172M
| $286K | ﹤0.01% |
112,208
+35,040
| +45% | +$91.3K |
|
6208
Pro-Dex
PDEX
$209M
| $286K | ﹤0.01% |
6,116
+1,749
| +40% | +$71.3K |
|
6209
Ponce Financial Group
PDLB
$485M
| $285K | ﹤0.01% |
21,949
+12,688
| +137% | +$156K |
|
6210
Telos
TLS
$358M
| $285K | ﹤0.01% |
83,427
+33,811
| +68% | +$121K |
|
6211
Invesco BulletShares 2033 Corporate Bond ETF
BSCX
$1.03B
| $285K | ﹤0.01% |
13,833
-883
| -6% | -$18.6K |
|
|
AILE
6212
DELISTED
iLearningEngines, Inc. Common Stock
AILE
| $285K | ﹤0.01% |
679,089
+656,775
| +2,943% | +$843K |
|
6213
Nektar Therapeutics
NKTR
$2.58B
| $285K | ﹤0.01% |
20,395
+12,894
| +172% | +$227K |
|
6214
Seres Therapeutics
MCRB
$48.4M
| $284K | ﹤0.01% |
17,116
+15,396
| +895% | +$250K |
|
6215
Babcock & Wilcox
BW
$1.39B
| $284K | ﹤0.01% |
173,068
+122,687
| +244% | +$259K |
|
6216
VanEck Morningstar International Moat ETF
MOTI
$76.9M
| $282K | ﹤0.01% |
+9,295
| New | +$305K |
|
6217
Lincoln Educational Services
LINC
$1.3B
| $281K | ﹤0.01% |
17,791
-25,840
| -59% | -$376K |
|
6218
CALL
Evolent Health
EVH
$447M
| $281K | ﹤0.01% |
25,000
| – | – |
|
6219
Bridgewater Bancshares
BWB
$603M
| $281K | ﹤0.01% |
20,798
+8,758
| +73% | +$129K |
|
|
EDF
6220
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$171M
| $281K | ﹤0.01% |
59,754
+22,237
| +59% | +$111K |
|
6221
PUT
Jacobs Solutions
J
$17B
| $281K | ﹤0.01% |
2,121
| – | – |
|
6222
TScan Therapeutics
TCRX
$52M
| $279K | ﹤0.01% |
91,860
+72,516
| +375% | +$329K |
|
|
SEG
6223
Seaport Entertainment Group
SEG
$362M
| $279K | ﹤0.01% |
9,991
+3,725
| +59% | +$107K |
|
6224
ACNB Corp
ACNB
$655M
| $279K | ﹤0.01% |
7,004
+2,997
| +75% | +$133K |
|
6225
CALL
Amphenol
APH
$209B
| $279K | ﹤0.01% |
4,016
-11,546
| -74% | -$808K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.